Company Overview and News

0
KEI Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KEI 517569

0
KEI Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KEI 517569

0
KEI Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KEI 517569

0
KEI Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-06-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KEI 517569

0
KEI Industries: Poised for higher growth, great long-term bet

2018-05-21 moneycontrol
In the engineering and power space, KEI Industries is probably the only company which is not complaining about slowing demand and capex cycle. It is operating at over 90 percent capacity utilisation and delivered a strong 24 percent year-and-year growth in revenue last fiscal.
KEI 517569

0
KEI Industries Limited - Press Release

2018-05-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KEI 517569

0
KEI Industries Limited - Outcome of Board Meeting

2018-05-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KEI 517569

43
Market Live: Sensex under pressure as Brent crude nears $80/bbl; Midcap index outperforms

2018-05-17 moneycontrol
Equity benchmarks have continued to trade lower for the second consecutive day as Sensex fell over 100 points. The Nifty was holding on to 10,700-mark. Among sectoral indices, IT is having a good day of trade, with Nifty IT trading 0.37 percent. Cuts are visible among FMCG names, led by a fall in ITC. Midcaps, however, are outperforming the benchmarks, trading over 0.4 percent higher. Coal India, Tata Motors, Bajaj Finserv and Bajaj Finance are the top gainers among both indices, while ITC, Bharti Airtel and Hindalco have lost the most.
DVSLY 500325 BHUSANSTL MCDHOLDING 517569 532712 RCOM 532482 534816 BJJQY 500570 KIRLOSIND CLNDY VLSFINANCE 502355 500055 RLNIY ORIENTREF 517214 BAJAJFINSV BAJFINANCE TATASTEEL TATLY 500180 COALINDIA BALKRISIND BHRYY RELIANCE 532978 530239 BHRQY 533278 JTLINFRA 534600 SUVEN 532852 GRANULES 500470 532461 KEI RIGD INFRATEL HDFCBANK BHARTIARTL TATAMOTORS 500034 HINDALCO IBN 534076 533023 TAKE 511333 532454 HNDNF SPICEMOBI ICICIBANK TTST PNJZY 532890 HDB 532174 PNB WABCOINDIA 500440 500243 TTM

0
KEI Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KEI 517569

0
KEI Industries Limited - Credit Rating

2018-03-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KEI 517569

0
KEI Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-03-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
KEI 517569

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...